Milestone Scientific (NYSEAMERICAN:MLSS) released its quarterly earnings results on Tuesday. The medical instruments supplier reported ($0.01) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.01, MarketWatch Earnings reports. Milestone Scientific had a negative net margin of 165.06% and a negative return on equity of 104.43%.
Milestone Scientific stock opened at $3.72 on Friday. The company has a market cap of $236.94 million, a PE ratio of -23.25 and a beta of 1.54. Milestone Scientific has a twelve month low of $0.85 and a twelve month high of $4.85. The firm has a 50-day moving average of $1.89.
In other news, CEO Leonard Osser sold 45,240 shares of the firm’s stock in a transaction that occurred on Thursday, January 7th. The shares were sold at an average price of $2.20, for a total transaction of $99,528.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Giandomenico Trombetta sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, February 8th. The stock was sold at an average price of $3.35, for a total transaction of $33,500.00. Following the transaction, the director now directly owns 9,933,855 shares in the company, valued at $33,278,414.25. The disclosure for this sale can be found here. Over the last three months, insiders sold 294,908 shares of company stock worth $717,981. Insiders own 27.32% of the company’s stock.
About Milestone Scientific
Milestone Scientific, Inc develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent System that are used to control the flow rate of the anesthesia during the injection, which allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns.
Read More: Trading on Margin
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.